Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2008
05/13/2008US7371824 PRO6093 polypeptides
05/13/2008US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction
05/13/2008US7371817 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis
05/13/2008US7371815 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
05/13/2008US7371811 Polypeptide of given sequence; diagnosis and treatment of bipolar disorders
05/13/2008US7371810 Tachykinin peptides, precursor peptides thereof and genes encoding the same
05/13/2008US7371735 Inhibitor oligonucleotides and their use for specific repression of a gene
05/13/2008US7371723 Therapeutic agents comprising pro-apoptotic proteins
05/13/2008US7371577 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
05/13/2008US7371576 CD56 positive human adult pancreatic endocrine progenitor cells
05/13/2008US7371575 Process for ex vivo formation of mammalian bone and uses thereof
05/13/2008US7371574 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability
05/13/2008US7371573 Propagation and/or derivation of embryonic stem cells
05/13/2008US7371570 replication-competent; comprising an epstein-barr virus (EBV)-specific transcriptional regulatory element (TRE); genetic engineering
05/13/2008US7371569 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures
05/13/2008US7371568 Centromere, telomere and recognition sequences for recombinase; fragment comprising antibody gene; site-directed recombination detected by green fluorescent protein
05/13/2008US7371559 Polynucleotide of given sequence; treatment of chronic pain, migraine, asthma, urge incontinence, psoriasis, and cancer
05/13/2008US7371555 Polypeptides having α-H-α-amino acid amide racemase activity and nucleic acids encoding the same
05/13/2008US7371543 Factor VII or VIIa-like molecules
05/13/2008US7371540 Encodes a protein that interacts with human CD33, the DNA being highly homologous to a portion of the human dystrophin gene. screening for leukemic cells and associated disease states; gene therapy
05/13/2008US7371535 Detect binding with cells transfected with DNA
05/13/2008US7371529 Methods and compositions for modulating gluconeogenesis using PGC-1
05/13/2008US7371518 Universal collection medium
05/13/2008US7371517 High purity X-chromosome bearing and Y-chromosome bearing populations of spermatozoa
05/13/2008US7371515 Detection of cancer genes in sample; obtain cells, transform with vector, detect cell in which tumor development has been induced, detect gene associated with cancer
05/13/2008US7371513 Method of preserving corneal tissue using polyoxyethylene/polyoxypropylene copolymer
05/13/2008US7371417 plant extracts used as adjuvants for DNA vaccines, to improve immune responses in mammals
05/13/2008US7371400 Multilayer device for tissue engineering
05/13/2008US7371377 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; tissue engineering; bradycardial agents
05/13/2008US7371374 Neural transplantation using pluripotent neuroepithelial cells
05/13/2008US7371370 Using colony stimulating factor comprising amino acid sequence variation as therapeutic tools in treatment and prevention of hematopoietic, neurological or reproduction disorders
05/13/2008US7371366 GlcNAc phosphotransferase of the lysosomal targeting pathway
05/13/2008CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89)
05/13/2008CA2336261C Cyclin e2 genes and proteins
05/13/2008CA2298869C Astaxanthin synthetase
05/13/2008CA2166291C Htlv-iinra compositions and assays for detecting htlv infection
05/13/2008CA1341573C Recombinant gamma interferons having enhanced stability and methods therefor
05/08/2008WO2008055224A2 Lithium stimulation of cord blood stem cell proliferation and growth factor production
05/08/2008WO2008055069A2 Poultry vaccine, for necrotic enteritis, comprising a mutated clostridium perfringens alpha toxin antigen, and methods of producing the vaccine
05/08/2008WO2008054825A2 Mixed cell populations for tissue repair and separation technique for cell processing
05/08/2008WO2008054819A2 Cardiovascular stem cells, methods for stem cell isolation, and uses thereof
05/08/2008WO2008054716A2 Methods for identifying, isolating, and utilizing endocrine progenitor cells from adult human pancreata
05/08/2008WO2008054540A2 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
05/08/2008WO2008054030A1 IgG-BINDING PEPTIDE
05/08/2008WO2008053909A1 Agent for controlling growth and/or differentiation of mesenchymal stem cell
05/08/2008WO2008053901A1 METHOD FOR ANALYSIS OF HEPATITIS B VIRUS s ANTIGEN
05/08/2008WO2008053892A1 Pharmaceutical for promoting functional regeneration of damaged tissue
05/08/2008WO2008053588A1 Cytokine production regulator gene and use thereof
05/08/2008WO2008053573A1 Remedy for malignant neoplasm
05/08/2008WO2008053059A1 Use of the ocp3 mutation to regulate drought resistance in plants
05/08/2008WO2008052963A1 Labeling of human epidermal stem cells
05/08/2008WO2008052740A2 Method for stimulating dendritic cells and cell product thus obtained for the autologous immunotherapy of solid human tumours
05/08/2008WO2008052478A1 Grain incomplete filling gene (gif1) and uses thereof
05/08/2008WO2008052285A1 Transcriptional control sequences
05/08/2008WO2008031910A3 Experimental models for non-microcytic lung cancer metastasis to bone
05/08/2008WO2008016958B1 Reproductive cell media compositions and methods for improving fertility
05/08/2008WO2008014970A3 Process for cell proliferation
05/08/2008WO2008001219A3 Cancer therapy using bcl-xl-specific sina
05/08/2008WO2007144903A3 A hybrid cell vaccine against leishmaniasis [kala-azar]
05/08/2008WO2007113285A3 Mono- and bifunctional molecules with ability to bind to g protein-coupled receptors
05/08/2008WO1999048916A8 Hypoxia-inducible human genes, proteins, and uses thereof
05/08/2008US20080109923 Expression of spider silk proteins in higher plants
05/08/2008US20080109918 Materials and methods for tissue-specific targeting of ethylene insensitivity in transgenic plants
05/08/2008US20080109917 Card-domain containing polypeptides, encoding nucleic acids, and methods of use
05/08/2008US20080109915 Hair follicle-reconstitution system and animal carrying the same
05/08/2008US20080109914 Using reporter protein expression as diagnostic tool in classification nervous system tissue; neuroprotective agents
05/08/2008US20080109654 System and method for RFID transfer of MAC, keys
05/08/2008US20080108796 Human IL-1 epsilon DNA and polypeptides
05/08/2008US20080108600 Polycyclic Pyridines as Potassium Ion Channel Modulators
05/08/2008US20080108584 dsRNA with a sense strand containing a first sequence, an antisense strand containing a second sequence, comprises a nucleotide sequence which is substantially complementary to mRNA encoding IKK-B, upon contact with a cell expressing IKK-B, Inhibits IKK-B gene expression; antiinflammatory agent
05/08/2008US20080108574 Melanocortin receptor mediated modulation of neurogenesis
05/08/2008US20080108569 Compositions and Methods for Treating Diseases Associated With Phlpp
05/08/2008US20080108565 An immunoglobulin heavy chain variable region, an immunoglobulin light chain variable region, together define a single binding site for binding human HGF; neutralizing the activity of HGF
05/08/2008US20080108560 Heterologous G-Csf Fusion Proteins
05/08/2008US20080108553 Rationally designed media for cell culture
05/08/2008US20080108552 Beta 1-integrin inhibitory peptide modified by biotin, cystein, or carboxyfluorescein (FAM)
05/08/2008US20080108551 Treatment of wounds
05/08/2008US20080108547 Protease Inhibitor
05/08/2008US20080108511 Genes and gene products differentially expressed during heart failure
05/08/2008US20080108502 Sodium/potassium cotransporter proteins (HKT); site-directed mutagenesis
05/08/2008US20080108140 CEACAM1 Mediated Protective Immunity
05/08/2008US20080108139 Composition of matter comprising primary nucleic acid component
05/08/2008US20080108138 Solid support comprising thin film and immobilized cell fate modulator for use in controlling tissue development in a three-dimensional environment
05/08/2008US20080108137 Dispersion Devices For Aggregates
05/08/2008US20080108136 Propagating progenitor cells in culture without differentiation; for use in stem cell transplantation
05/08/2008US20080108135 Using immunoglobulin fusion to deliver effector cells; tissue targeted therapy; antitumor agents
05/08/2008US20080108134 Extracellular matrix tisuse comprised of cultured fibroblast for use in grafting to patient with tissue or organ defect; safety testing for pharmaceutical, cosmetic and chemical products
05/08/2008US20080108133 Adenocarcinoma Specific Antibody Sam-6, and Uses Thereof
05/08/2008US20080108128 Resonance Energy Transfer Assay System for Multi-Component Detection
05/08/2008US20080108106 Glycolysis-inhibiting substances in cell culture
05/08/2008US20080108105 Transcription factor for enhancing genic expression in microorganismal host
05/08/2008US20080108092 Tumor suppressor specific immunoblobulin for use in diagnosis/prognosis of cell proliferative disorders of prostate
05/08/2008US20080108091 Proteomic Patterns of Cancer Prognostic and Predictive Signatures
05/08/2008US20080108088 Using g protein coupled receptor to identify modulators of taste signal transduction; generating of taste topographic maps that elucidate relationship between taste cells of tongue and taste sensory neurons in brain
05/08/2008US20080108084 Cancer Detection Methods and Reagents
05/08/2008US20080108067 Cloning of the retinoic acid inducible gene-1 promoter and uses thereof
05/08/2008US20080108053 Compositions and methods for purifying and crystallizing molecules of interest
05/08/2008US20080108047 Method for Separating Cells
05/08/2008US20080108046 Method of sorting cells
05/08/2008US20080108044 In vitro differentiation of hematopoietic cells from primate embryonic stem cells